![]() |
||||||||||||||||||||||||||||||||
|
|
|
|||||||||||||||||||||||||||||||
|
The GluCath®system is a single-use, intravascular continuous glucose monitor. It combines a unique fluorescent chemistry with a proven optical technology platform used for the monitoring of hospitalized patients.
|
The GluCath system is an invesitgational device currently undergoing clinical testing to confirm the performance and functionality of the device. The GluCath system is not currently available for distribution.
|
|
| GluMetrics has established a signficant intellectual property position through the discovery, acquisition and/or licensing of key patents relating to the composition and preparation of fluorescent chemistry and polymer compounds. All assets, know-how, IP and trade secrets of Diametrics Medical, Inc. relating to the continuous intravascular measurement of blood constituents including glucose were acquired in July 2006 through the acquisition of TGC Research, Ltd. |